Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order to avoid the beginning of disease-induced attacks and other long-term effects of porphyria   Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of...

Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products   London   Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic...

During our research, we came across over 43 companies that are presently engaged in the development of DDR targeting therapeutics. There has been a significant increase in the number of developers that have been established in this domain post-2008. In fact, close to XX players were established during the period 2013-2016. Further, over XX developers have been founded since 2017.  To...

A major increase in the number of different types of solutions for treating various indications, has been observed in the past two years. In fact, from June 2018 to in June 2020, there has been increase of 22 approved and 106 marketed digital therapeutic products.   To order this 130+ slides report, which features 80+ figures, please visit...

The primary purpose of this analysis was to develop a deeper understanding of the overall strength of the contract service providers involved in this field. It allows companies to compare their existing capabilities within their respective peer groups and identify ways to gain a competitive edge in the industry. In addition, this analysis can be used by the companies to ascertain improvement...

The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy   London   Roots Analysis has announced the addition of “Progressive Supranuclear Palsy Therapies Market, 2021-2030”...

Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order to avoid the beginning of disease-induced attacks and other long-term effects of porphyria   Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of...

Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products   London   Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic...

The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative disease   Roots Analysis has announced the addition of “Alzheimer's Disease Market (2nd Edition), 2021-2031” report to its list...

The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative disease   Roots Analysis has announced the addition of “Alzheimer's Disease Market (2nd Edition), 2021-2031” report to its list...